A Member of the Cancer Information Network
Cancer Information by State:
  arrow Patient Home   arrow Professional Home   arrow Newsletters   arrow Feedback Survey  
Main Menu
Quick Links
Information by Disease
Cancer News
Conference Coverage
Oncology Stocks
AZN$44.82-0.37 (-0.82%)
NVS$53.13-0.16 (-0.3%)
SNY$37.67-0.01 (-0.03%)
GSK$41.530.06 (0.14%)
click here
Regulatory News: Article   Printable Version 


Regulatory News Article
Complete SE Biliary Stent System Receives Marketing Clearance

The United States Food and Drug Administration (FDA) has granted Medtronic Inc. clearance for marketing for their biliary stent system for the treatment of malignancies of the bile duct.

Medtronic Inc.’s medical device will be marketed under the name Complete SE (self-expanding) Biliary Stent System.

Commercial sales within the United States will begin immediately, according to Medtronic Inc.



© 1998-2007 OncoEd.com All Rights Reserved.

These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers should verify all information and data before administering any drug, therapy or treatment discussed herein. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained herein.
© 1998-2007 OncoEd, Inc  All Rights Reserved.

These materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. All readers should verify all information and data before administering any drug, therapy or treatment discussed herein. Neither the editors nor the publisher accepts any responsibility for the accuracy of the information or consequences from the use or misuse of the information contained herein.




   




© 1998-2007 CancerConsultants.com  All Rights Reserved.